BiotechTube
Home/Anokion/Matthew B. Frankel
MB

Matthew B. Frankel

Chief Medical Officer

Anokion

Therapeutic Areas

Autoimmune DiseasesCeliac DiseaseMultiple Sclerosis

Anokion Pipeline

DrugIndicationPhase
ANK-700Celiac DiseasePhase 1b/2
ANK-800Multiple SclerosisPhase 1

Leadership Team at Anokion

DG
Deborah Geraghty
Chief Executive Officer
JH
John H. B. Johnson
Chief Scientific Officer
View full Anokion profile